Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019041469) NEW USE OF POLYNUCLEOTIDE-5' KINASE-3' PHOSPHATASE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/041469 International Application No.: PCT/CN2017/106309
Publication Date: 07.03.2019 International Filing Date: 16.10.2017
IPC:
C12Q 1/68 (2018.01) ,G01N 33/574 (2006.01) ,A61K 31/585 (2006.01) ,A61P 35/00 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53
Immunoassay; Biospecific binding assay; Materials therefor
574
for cancer
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
56
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
58
containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin
585
containing lactone rings, e.g. oxandrolone, bufalin
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
苏州大学 SOOCHOW UNIVERSITY [CN/CN]; 中国江苏省苏州市 相城区济学路8号 No.8 Jixue Road, Xiangcheng District Suzhou, Jiangsu 215123, CN
Inventors:
周泉生 ZHOU, Quansheng; CN
曹志飞 CAO, Zhifei; CN
Agent:
北京集佳知识产权代理有限公司 UNITALEN ATTORNEYS AT LAW; 中国北京市 朝阳区建国门外大街22号赛特广场7层 7th Floor, Scitech Place No.22, Jian Guo Men Wai Ave., Chao Yang District Beijing 100004, CN
Priority Data:
201710757969.729.08.2017CN
Title (EN) NEW USE OF POLYNUCLEOTIDE-5' KINASE-3' PHOSPHATASE
(FR) NOUVELLE UTILISATION DE POLYNUCLÉOTIDE-5' KINASE-3' PHOSPHATASE
(ZH) 多聚核苷酸-5'激酶-3'磷酸酶的新应用
Abstract:
(EN) Provided is a new use of polynucleotide-5' kinase-3' phosphatase. In particular, provided is the use of polynucleotide-5' kinase-3' phosphatase in the preparation of products for diagnosing pancreatic cancer. Also provided is the use of triptonide as a polynucleotide-5' kinase-3' phosphatase inhibitor. Further provided is the use of polynucleotide-5' kinase-3' phosphatase as a target in the preparation of a drug for treating pancreatic cancer.
(FR) L'invention concerne une nouvelle utilisation de la polynucléotide-5' kinase-3' phosphatase. En particulier, l'invention concerne l'utilisation de la polynucléotide-5' kinase-3' phosphatase dans la préparation de produits pour le diagnostic du cancer du pancréas. L'invention concerne également l'utilisation de triptonide en tant qu'inhibiteur de la polynucléotide-5' kinase-3' phosphatase. L'invention concerne également l'utilisation de la polynucléotide-5' kinase-3' phosphatase en tant que cible dans la préparation d'un médicament pour le traitement du cancer du pancréas.
(ZH) 本发明提供了多聚核苷酸-5'激酶-3'磷酸酶的新应用,具体地,提供了多聚核苷酸-5'激酶-3'磷酸酶在制备诊断胰腺癌的产品中的应用。本发明还提供了雷公藤内酯酮作为多聚核苷酸-5'激酶-3'磷酸酶抑制剂的应用。本发明进一步还提供了以多聚核苷酸-5'激酶-3'磷酸酶为靶标在制备治疗胰腺癌的药物中的应用。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)